Log In
Print
BCIQ
Print
Print this Print this
 

PT001

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionGlycopyrrolate, a long-acting muscarinic antagonist (LAMA) delivered via a metered-dose hydrofluoroalkane (HFA) inhaler
Molecular Target Muscarinic receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD); Treat moderate to very severe chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today